Since it was established as a cord blood bank, FamiCord focuses mainly on providing cord blood banking services to families in Europe. The majority of our customers are contacted by FamiCord’s own personnel, in some countries specialized agents are appointed.
FamiCord’s role is to collect, process, test and store cord blood. Cord blood derived stem cells are released from storage for transplantation when it is needed. FamiCord specialists are actively supporting this life saving process, which has been proven by more than 400 successful transplantations carried out in several transplantation clinics located in different countries and continents. In 2015 Institute of Stem Cells Therapies was established, its aim is to introduce therapies using mesenchymal stem cells.
FamiCord laboratories also process other tissues (i.e. umbilical cord tissue, placenta) which are a rich source of mesenchymal stem cells. These cells have also been used for transplantations .In 2015, FamiCord AG in Switzerland was established, as well as the Institute of Stem Cells Therapies, which aims to introduce therapies using mesenchymal stem cells.
Since 2011 FamiCord has been building an inventory of cord blood for public use. Now more than 3000 high quality cord blood units are available for unrelated recipients all over the world. This is the largest public inventory of cord blood available among European family banks.
FamiCord® Group facts and figures:
- over 140 000 cord blood units stored to date
- 23 cord blood transplantations (13 in Poland, 4 in Hungary, 5 in Turkey, 1 in Jordan)
- 7 laboratory facilities: Poland (3), Hungary, Romania, Spain, Turkey
- Over 400 patients treated with mesenchymal stem cells
- Cooperation with over 1100 hospitals around Europe